Zhi Xiong

Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Daidzein-engineered high-accumulation self-therapeutic nanoplatform drives androgen receptor degradation via ubiquitination-proteasome system to overcome enzalutamide resistance in castration-resistant prostate cancer.

Daidzein-engineered high-accumulation self-therapeutic nanoplatform drives androgen receptor degradation via ubiquitination-proteasome system to overcome enzalutamide resistance in castration-resistant prostate cancer.

Journal: Materials today. Bio

Published: July 25, 2025

PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer.

PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer.

Journal: Cell death & disease

Published: July 24, 2025

LGR5 interacts with HSP90AB1 to mediate enzalutamide resistance by activating the WNT/β-catenin/AR axis in prostate cancer.

LGR5 interacts with HSP90AB1 to mediate enzalutamide resistance by activating the WNT/β-catenin/AR axis in prostate cancer.

Journal: Chinese medical journal

Published: November 27, 2024

Monitoring rapid degradation of NANOG reveals UTP15 maintains pluripotency by regulating nascent transcripts.

Monitoring rapid degradation of NANOG reveals UTP15 maintains pluripotency by regulating nascent transcripts.

Journal: Nature communications

Published: November 27, 2024

Modeling and Visual Simulation of Bifurcation Aneurysms Using Smoothed Particle Hydrodynamics and Murray's Law.

Modeling and Visual Simulation of Bifurcation Aneurysms Using Smoothed Particle Hydrodynamics and Murray's Law.

Journal: Bioengineering (Basel, Switzerland)

Published: November 09, 2024

Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer.

Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer.

Journal: Journal of advanced research

Published: September 23, 2024

Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer Therapy.

Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer Therapy.

Journal: ACS biomaterials science & engineering

Published: June 08, 2024

Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression.

Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression.

Journal: Biomaterials science

Published: January 03, 2024

KMT2D deficiency leads to cellular developmental disorders and enhancer dysregulation in neural-crest-containing brain organoids.

KMT2D deficiency leads to cellular developmental disorders and enhancer dysregulation in neural-crest-containing brain organoids.

Journal: Science bulletin

Published: December 30, 2023

Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study.

Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study.

Journal: Cancer pathogenesis and therapy

Published: December 16, 2023

Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis.

Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis.

Journal: iScience

Published: October 21, 2023

Osteocytes/Osteoblasts Produce SAA3 to Regulate Hepatic Metabolism of Cholesterol.

Osteocytes/Osteoblasts Produce SAA3 to Regulate Hepatic Metabolism of Cholesterol.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 17, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026